Brief: Day One Reports Third Quarter 2021 Financial Results

Day One Biopharmaceuticals

08/11/2021 22:00

Nov 8 (Reuters) - Day One Biopharmaceuticals Inc  DAWN.O :
    * DAY ONE REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS AND
CORPORATE PROGRESS
    * BELIEVES IT HAS SUFFICIENT CAPITAL RESOURCES TO FUND
ANTICIPATED
OPERATIONS INTO SECOND HALF OF 2023
    * QTRLY LOSS PER SHARE $0.33
    * Q3 EARNINGS PER SHARE VIEW $-0.28 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX97XGMH 
Further company coverage:  DAWN.O 

 ((Reuters.Briefs@thomsonreuters.com;))